Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · IEX Real-Time Price · USD
2.350
-0.080 (-3.29%)
May 17, 2024, 11:45 AM EDT - Market closed
Barinthus Biotherapeutics Market Cap
Barinthus Biotherapeutics has a market cap or net worth of $91.54 million as of May 17, 2024. Its market cap has increased by 5.22% in one year.
Market Cap
91.54M
Enterprise Value
-25.63M
1-Year Change
5.22%
Ranking
Category
Stock Price
$2.35
Market Cap Chart
Since the IPO on April 30, 2021, Barinthus Biotherapeutics's market cap has decreased from $579.09M to $91.54M, a decrease of -84.19%. That is a compound annual growth rate of -45.39%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 91.70M | -3.37% |
May 16, 2024 | 94.90M | 9.33% |
May 15, 2024 | 86.80M | -4.19% |
May 14, 2024 | 90.60M | -0.98% |
May 13, 2024 | 91.50M | 0.66% |
May 10, 2024 | 90.90M | -0.66% |
May 9, 2024 | 91.50M | 3.51% |
May 8, 2024 | 88.40M | - |
May 7, 2024 | 88.40M | 2.79% |
May 6, 2024 | 86.00M | 1.42% |
May 3, 2024 | 84.80M | 1.56% |
May 2, 2024 | 83.50M | -2.45% |
May 1, 2024 | 85.60M | 7.27% |
Apr 30, 2024 | 79.80M | -20.83% |
Apr 29, 2024 | 100.80M | 3.60% |
Apr 26, 2024 | 97.30M | 2.96% |
Apr 25, 2024 | 94.50M | -3.28% |
Apr 24, 2024 | 97.70M | -1.51% |
Apr 23, 2024 | 99.20M | -2.75% |
Apr 22, 2024 | 102.00M | 4.40% |
Apr 19, 2024 | 97.70M | -7.39% |
Apr 18, 2024 | 105.50M | 4.25% |
Apr 17, 2024 | 101.20M | 2.74% |
Apr 16, 2024 | 98.50M | -4.18% |
Apr 15, 2024 | 102.80M | -15.88% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Oramed Pharmaceuticals | 93.85M |
Xtant Medical Holdings | 93.77M |
Eton Pharmaceuticals | 93.13M |
Milestone Pharmaceuticals | 92.94M |
Elutia | 92.79M |
IO Biotech | 90.92M |
Anixa Biosciences | 90.60M |
BrainsWay | 90.08M |